Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor Negative Neoplasm|HER-2 Positive Breast Cancer
Interventions: DRUG: nab-paclitaxel|DRUG: Trastuzumab
Sponsor: Osaka Medical College